Literature DB >> 35050314

Comparison of mRNA-1273 and BNT162b2 Vaccines on Breakthrough SARS-CoV-2 Infections, Hospitalizations, and Death During the Delta-Predominant Period.

Lindsey Wang1, Pamela B Davis2, David C Kaelber3, Nora D Volkow4, Rong Xu1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35050314      PMCID： PMC8778597          DOI： 10.1001/jama.2022.0210

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   157.335


× No keyword cloud information.
  14 in total

1.  Durability analysis of the highly effective BNT162b2 vaccine against COVID-19.

Authors:  Arjun Puranik; Patrick J Lenehan; John C O'Horo; Colin Pawlowski; Michiel J M Niesen; Abinash Virk; Melanie D Swift; Walter Kremers; A J Venkatakrishnan; Joel E Gordon; Holly L Geyer; Leigh Lewis Speicher; Venky Soundararajan; Andrew D Badley
Journal:  PNAS Nexus       Date:  2022-06-08

2.  Association of Cerebral Venous Thrombosis with mRNA COVID-19 Vaccines: A Disproportionality Analysis of the World Health Organization Pharmacovigilance Database.

Authors:  Jin Park; Moo-Seok Park; Hyung Jun Kim; Tae-Jin Song
Journal:  Vaccines (Basel)       Date:  2022-05-18

3.  SARS-CoV-2 vaccination in the immunocompromised host.

Authors:  Caoilfhionn M Connolly; Julie J Paik
Journal:  J Allergy Clin Immunol       Date:  2022-05-12       Impact factor: 14.290

4.  Humoral Response in Hemodialysis Patients Following COVID-19 Vaccination and Breakthrough Infections during Delta and Omicron Variant Predominance.

Authors:  Rajkumar Chinnadurai; Henry H L Wu; Eleanor Cox; Jayne Moore; Toni Clough; Elizabeth Lamerton; Rosie Donne; Edmond O'Riordan; Dimitrios Poulikakos
Journal:  Vaccines (Basel)       Date:  2022-03-24

Review 5.  COVID-19 breakthrough infections, hospitalizations and mortality in fully vaccinated patients with hematologic malignancies: A clarion call for maintaining mitigation and ramping-up research.

Authors:  Lindsey Wang; David C Kaelber; Rong Xu; Nathan A Berger
Journal:  Blood Rev       Date:  2022-01-31       Impact factor: 10.626

6.  Humoral response following SARS-CoV-2 vaccination: not all immunosuppressants are created equal.

Authors:  Caoilfhionn M Connolly; Julie J Paik
Journal:  Lancet Rheumatol       Date:  2022-03-17

7.  The SARS-CoV-2 Delta variant induces an antibody response largely focused on class 1 and 2 antibody epitopes.

Authors:  Allison J Greaney; Rachel T Eguia; Tyler N Starr; Khadija Khan; Nicholas Franko; Jennifer K Logue; Sandra M Lord; Cate Speake; Helen Y Chu; Alex Sigal; Jesse D Bloom
Journal:  bioRxiv       Date:  2022-03-14

8.  Cellular and Humoral Responses Follow-up for 8 Months after Vaccination with mRNA-Based Anti-SARS-CoV-2 Vaccines.

Authors:  Sergio Gil-Manso; Diego Carbonell; Verónica Astrid Pérez-Fernández; Rocío López-Esteban; Roberto Alonso; Patricia Muñoz; Jordi Ochando; Ignacio Sánchez-Arcilla; Jose M Bellón; Rafael Correa-Rocha; Marjorie Pion
Journal:  Biomedicines       Date:  2022-07-12

9.  Breakthrough SARS-CoV-2 Infections, Hospitalizations, and Mortality in Vaccinated Patients With Cancer in the US Between December 2020 and November 2021.

Authors:  William Wang; David C Kaelber; Rong Xu; Nathan A Berger
Journal:  JAMA Oncol       Date:  2022-07-01       Impact factor: 33.006

10.  Seroconversion rate after primary vaccination with two doses of BNT162b2 versus mRNA-1273 in solid organ transplant recipients: a systematic review and meta-analysis.

Authors:  Arno Verleye; Veerle Wijtvliet; Steven Abrams; Rachel Hellemans; Rania Bougrea; Annick Massart; Lissa Pipeleers; Karl Martin Wissing; Kevin K Ariën; Benedicte Y De Winter; Pierre Van Damme; Daniel Abramowicz; Kristien J Ledeganck
Journal:  Nephrol Dial Transplant       Date:  2022-07-26       Impact factor: 7.186
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.